Searchable abstracts of presentations at key conferences in endocrinology

ea0011p415 | Diabetes, metabolism and cardiovascular | ECE2006

Cardiac autonomic neuropathy in relation to some components of metabolic syndrome in newly diagnosed type 2 diabetic patients

Nishnianidze MA , Kurashvili RB , Khelashvili MG , Tsutskiridze LR , Bekaia MG

Background and Aims: Components of metabolic syndrome (MS) carry an increased risk for cardiovascular disease (CVD). People with abnormal glucose regulation are more prone to develop complications. At diagnosis 20-30% of type 2 diabetic (T2DM) patients (pts) already have neuropathy-one of the most dangerous complications. Cardiac autonomic neuropathy (CAN) is associated with five-fold risk of mortality. Our aim was to study possible relation between CAN and some components of ...

ea0011p416 | Diabetes, metabolism and cardiovascular | ECE2006

Severity of depression in patients with type 1 and type 2 diabetes and its relation to the level of glycemia control and anti-depressive therapy

Tsutskiridze LR , Kurashvili RB , Kurashvili GR , Khelashvili MG , Nishnianidze MA , Shelestova EL , Dundua MG

Background and Aims: There are consistent findings about increased prevalence of depressive disorders in diabetes. The aim of the study was to reveal prevalence of depression in patients (pts) with type 1 (DM1) and type 2 (DM2) diabetes.Materials and Methods: Totally, 157 pts with DM were questioned. To assess depression degree Beck’s scale was used, and 83 depressive pts (scores >10), were allocated into 2 groups (Gr.): Gr.1 (n=44)–...

ea0011p417 | Diabetes, metabolism and cardiovascular | ECE2006

Cardiac autonomic and peripheral neuropathy in newly diagnosed type 2 diabetic patients

Kurashvili GR , Kurashvili RB , Khelashvili MG , Tsutskiridze LR , Shelestova EL , Kobaidze MN

Background and Aims: At diagnosis 20–30% of patients (pts) with type2 diabetes (T2DM) have neuropathy, that often goes unrecognized. Cardiac autonomic neuropathy (CAN) is associated with five-fold risk of mortality. As today there is no specific treatment for overt neuropathy, it is important to use prevention and timely revealing. The goal of the work was to evaluate prevalence of peripheral neuropathy and CAN in pts with newly diagnosed T2DM.Mater...